Gwenn M. Hansen, Ph.D., has served as Chief Scientific Officer of Nurix since June 2020 and served as the company’s Senior Vice President, Research from July 2019 through May 2020. Since joining Nurix in 2015, Dr. Hansen has focused on establishing the company’s DNA encoded library technology platform for small molecule discovery and leading the company’s discovery organization. Prior to joining Nurix, Dr. Hansen was an Associate Professor in the Center for Drug Discovery at Baylor College of Medicine and served in a variety of discovery-focused roles at Lexicon Pharmaceuticals. Dr. Hansen holds a B.A. in Biology from Gustavus Adolphus College and a Ph.D. in Biomedical Sciences from the University of Tennessee-Knoxville.
'